Print Departments and specialties Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments with related expertise Breast and Melanoma Surgical Oncology in Rochester Breast Clinic Breast Surgical Oncology in Jacksonville Cancer Care at Mayo Clinic Research A laboratory technician prepares samples for testing. Mayo Clinic researchers have a rich history in advancing precision medicine for breast cancer. Projects include: Finding new therapies for breast cancer Identifying an enzyme that regulates DNA repair Identifying subsets of women who do not benefit from cancer drugs called aromatase inhibitors Identifying genetic variations in the enzyme CYP2D6, which helps explain why some people with breast cancer don't respond to tamoxifen Developing a new drug to replace tamoxifen for people with low CYP2D6 enzyme activity Developing a new drug for women with resistance to aromatase inhibitors Identifying mechanisms for why some people do not respond to endocrine treatment, and then developing a new drug for breast cancer PublicationsSee a list of publications by Mayo Clinic doctors on precision medicine for breast cancer on PubMed, a service of the National Library of Medicine. Read more about breast cancer research laboratories and programs: Center for Individualized Medicine Breast Cancer SPORE Research Profiles Edit search filters close Narrow your search By location Arizona Florida Minnesota View all View all physicians • Minnesota Bakkum-Gamez, Jamie N. M.D. Minnesota Block, Matthew S. M.D., Ph.D. Minnesota Boughey, Judy C. M.D. Minnesota Cliby, Bill M.D. Minnesota Couch, Fergus J. Ph.D. Minnesota Degnim, Amy C. M.D. Minnesota Dowdy, Sean C. M.D. Minnesota Ehman, Richard L. M.D. Minnesota Goetz, Matthew P. M.D. Minnesota Goode, Ellen L. Ph.D. Minnesota Hawse, John R. IV Ph.D. Minnesota Hruska, Carrie B. Ph.D. Minnesota Jatoi, Aminah M.D. Minnesota Kannan, Nagarajan Ph.D., M.S. Minnesota Kaufmann, Scott H. M.D., Ph.D. Minnesota Khosla, Sundeep M.D. Minnesota Mariani, Andrea M.D., M.S. Minnesota Mutter, Robert W. M.D. Minnesota Oberg, Ann L. Ph.D. Minnesota Peng, Kah Whye Ph.D. Minnesota Rhodes, Deborah J. M.D. Minnesota Shridhar, Viji Ph.D. Minnesota Smith, David I. Ph.D. Minnesota Suman, Vera Ph.D. Minnesota Vachon, Celine M. Ph.D. Minnesota Walther-Antonio, Marina R. Ph.D. Minnesota Wang, Liewei M.D., Ph.D. Minnesota Weinshilboum, Richard M.D. Minnesota Weroha, John J. M.D., Ph.D. Minnesota By Mayo Clinic Staff Precision medicine for breast cancer care at Mayo Clinic Request an appointment Doctors & Departments July 11, 2024 Print Show references Jorde LB, et al., eds. Genetics and precision medicine. In: Medical Genetics. 6th ed. Elsevier; 2020. htps://www.clinicalkey.com. Accessed Dec. 21, 2023. Cyr AE, et al. Individualizing breast cancer risk assessment in clinical practice. Surgical Oncology Clinics of North America. 2023; doi:10.1016/j.soc.2023.05.013. Khan SA. Breast cancer risk reduction: Current status and emerging trends to increase efficacy and reduce toxicity of preventive medication. Surgical Oncology Clincs of North America. 2023; doi:10.1016/j.soc.2023.05.001. Reizine NM, et al. Modern developments in germline pharmacogenomics for oncology prescribing. CA: A Cancer Journal for Clinicians. 2022; doi:10.3322/caac.21722. Biomarker testing for cancer treatment. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment. Accessed Dec. 22, 2023. Liu T, et al. CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. Nature Communications. 2017; doi:10.1038/ncomms13923. Luo K, et al. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination. Genes & Development. 2016; doi:10.1101/gad.289439.116. Ingle JN, et al. Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy. Cancer Research. 2016; doi:10.1158/0008-5472.CAN-16-1371. Goetz MP, et al. CYP2D6 metabolism and patient outcome in the Austrian breast and colorectal cancer study group trial (ABCSG) 8. Clinical Cancer Research. 2013; doi:10.1158/1078-0432.CCR-12-2153. Goetz MP, et al. First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology. 2017; doi:10.1200/JCO.2017.73.3246. D'Assoro AB, et al. The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells. Oncogene. 2013; doi:10.1038/onc.2012.628. Ingle JN, et al. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole. Steroids. 2015; doi:10.1016/j.steroids.2014.08.007. Jayaraman S, et al. Endoxifen, an estrogen receptor targeted therapy: From bench to bedside. Endocrinology. 2021; doi:10.1210/endocr/bqab191. Goetz MP, et al. Tumor sequencing and patient-derived xenografts in the neoadjuvant treatment of breast cancer. Journal of the National Cancer Institute. 2017; doi:10.1093/jnci/djw306. Hu C, et al. Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay. Clinical Cancer Research. 2022; doi:10.1158/1078-0432.CCR-22-0203. Couch FJ, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncology. 2017; doi:10.1001/jamaoncol.2017.0424. Precision medicine initiative cohort program biobank. NIH RePORTER. https://reporter.nih.gov/search/QPpHrqO3ekG7Z4TLi-I3RA/project-details/10489966. Accessed Nov. 15, 2023. Biobank. National Institutes of Health. https://allofus.nih.gov/funding-and-program-partners/biobank. Accessed Nov. 15, 2023. 13th conference invited speakers. International Society for Applied Biological Sciences. https://isabs.hr/13th-conference-invited-speakers. Accessed Nov. 15, 2023. Founding members. Pharmacogenomics Global Research Network. https://pgrn.org/founders. Accessed Nov. 15, 2023. Members. Personalized Medicine Coalition. https://www.personalizedmedicinecoalition.org/membership/current-members. Accessed Nov. 15, 2023. Electronic Medical Records and Genomics (eMERGE) Network. National Human Genome Research Institute. https://www.genome.gov/Funded-Programs-Projects/Electronic-Medical-Records-and-Genomics-Network-eMERGE. Accessed Nov. 15, 2023. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed Nov. 15, 2023. Fowler GC, et al., eds. Pfenninger and Fowler's Procedures for Primary Care. 4th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed May 10, 2024. Related Breast cancer Mapping the Genome Products & Services A Book: Beyond Breast Cancer Precision medicine for breast cancerAboutDoctors &DepartmentsCare atMayo Clinic PRC-20321688 Patient Care & Health Information Tests & Procedures Precision medicine for breast cancer